Cafepharma Today

September 19 2024 - Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
Havas Lynx explores pharma marketers’ role in addressing climate health crisis
Roche reports positive data from Phase III influenza treatment trial
ICER mulls GSK COPD drugs ahead of next Medicare negotiation
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Alpharma adopts poison-pill plan to head off hostile takoever by King Pharmaceuticals
Yahoo/AP
Tuesday, September 2, 2008 - 11:19am
tags:
Introgen's Advexin Gets FDA Snub
The Street.com
Tuesday, September 2, 2008 - 11:18am
tags:
Study: No proof Vytorin linked to cancer; other doctors warn it should be used carefully
Yahoo/AP
Tuesday, September 2, 2008 - 10:30am
tags:
New England Journal of Medicine: Vytorin-Cancer Link ‘Uncertain’
WSJ Online
Tuesday, September 2, 2008 - 10:27am
tags:
Eli Lilly says olanzapine study shows treatment benefit for up to six months
Trading Markets
Tuesday, September 2, 2008 - 10:24am
tags:
Glaxo heart drug seen promising despite trial miss
Forbes
Tuesday, September 2, 2008 - 10:23am
tags:
Novo Nordisk says to boost U.S. marketing
Guardian, UK
Tuesday, September 2, 2008 - 10:18am
tags:
Three Biotech Stocks That Could Double
The Street.com
Tuesday, September 2, 2008 - 10:17am
tags:
GlaxoSmithKline scales back relationship with Adolor
Bizjournals.com
Tuesday, September 2, 2008 - 10:12am
tags:
Glaxo Drug Misses Main Study Goal, Still Has Promise
Bloomberg
Tuesday, September 2, 2008 - 10:11am
tags:
U.K.'s SkyePharma Drops Most in 16 Years on Share-Sale Plan
Bloomberg
Tuesday, September 2, 2008 - 10:10am
tags:
Sciele a Buy Since January
Zacks.com
Tuesday, September 2, 2008 - 10:09am
tags:
Questions Arise Again on Vytorin Cancer Risk
CNBC
Tuesday, September 2, 2008 - 9:02am
tags:
Novacea to merge; Transcept to hold 60% of new firm
Marketwatch
Tuesday, September 2, 2008 - 9:00am
tags:
Boehringer Ingelheim: Phase III Dabigatran Data 2Q Or 3Q 09
CNN Money
Tuesday, September 2, 2008 - 8:59am
tags:
Biotech Outlook: M&A to Continue
Zacks.com
Tuesday, September 2, 2008 - 8:54am
tags:
Mylan's Alphapharm wins patent litigation on generic Razadyne tablets
Pharmaceutical Business Review
Tuesday, September 2, 2008 - 8:50am
tags:
Study: Drug sales may not benefit from ads directed to patients
USA Today
Tuesday, September 2, 2008 - 8:50am
tags:
China's Hepatitis B Market to Double by 2012
Seeking Alpha
Monday, September 1, 2008 - 11:33am
tags:
Glaxo Loses Preemption Ruling In Paxil Suicide
Pharmalot
Monday, September 1, 2008 - 11:32am
tags:

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

FDA Approves Fasenra for Eosinophilic Granulomatosis with Polyangiitis
pharmexec
FDA Approves Keytruda Plus Pemetrexed, Platinum Chemotherapy for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma
pharmexec
Keytruda Demonstrates Superior Overall Survival vs. Yervoy in Advanced Melanoma
pharmexec
CAR-T For Autoimmune Disorders
In the Pipeline
A Better Response to Inflammation: Q&A with Dr. Ira Spector
pharmexec
Braftovi Plus Mektovi Demonstrates Sustained Efficiency in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
pharmexec
GSK Launches Brooke Shields’ Led Campaign Promoting Shingles Vaccine
pharmexec
Pharma Pulse: 9/18/24: How Drug Shortages Affect Pharmacovigilance, Long Strange Trip Continues for Psychedelics & more
pharmexec
Pharmaceutical Executive: September 2024 Issue (PDF)
pharmexec

Latest Jobs

Account Manager-Los Angeles-Ophthalmics
Los Angeles, California, 90079
Sun Pharmaceutical Industries, Inc.
Regional Sales Manager - Eyecare - East Region
Miami, Florida, 33222
PV8 US Innovex Inc.
Business Development Manager- Tampa, Florida
Tampa, Florida, 33646
Hanger Clinic
Neuroscience Account Manager (Psychiatry) - Burbank, CA
Burbank, California, 91520
Vanda Pharmaceuticals
Territory Account Associate- Grand Rapids, MI
Grand Rapids, Michigan, 49528
Amplity Health
Surgical Solutions Field Sales Associate - Remote
Milwaukee, Wisconsin, 53244
W.L. Gore & Associates
Manager, Business Development - Physician Relations - Days - Full-Time
Baton Rouge, Louisiana, 70873
Woman's Hospital
Area Business Manager - Pulmonology - Greenville, SC
Asheville, North Carolina, 28814
Sanofi
Area Manager, Specialty Atlantic Region
Fields, Oregon, 97710
CSL Behring
Territory Manager (PCP) (Madison, AL)
Huntsville, Alabama, 35824
Bausch Health
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information